Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Frontline Management of Epithelial Ovarian Cancer-Combining Clinical Expertise with Community Practice Collaboration and Cutting-Edge Research.
J Clin Med. 2020 Sep 1;9(9):2830. doi: 10.3390/jcm9092830.
J Clin Med. 2020.
PMID: 32882942
Free PMC article.
Review.
POLD1 DEDD Motif Mutation Confers Hypermutation in Endometrial Cancer and Durable Response to Pembrolizumab.
Wei CH, Wang EW, Ma L, Zhou Y, Zheng L, Hampel H, Shehayeb S, Lee S, Cohen J, Kohut A, Fan F, Rosen S, Wu X, Shen B, Zhao Y.
Wei CH, et al. Among authors: wang ew.
Cancers (Basel). 2023 Nov 30;15(23):5674. doi: 10.3390/cancers15235674.
Cancers (Basel). 2023.
PMID: 38067377
Free PMC article.
Item in Clipboard
Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL.
Liang R, Yao Y, Wang G, Yue E, Yang G, Qi X, Wang Y, Zhao L, Zheng T, Zhang Y, Wenge Wang E.
Liang R, et al. Among authors: wenge wang e.
Front Oncol. 2020 Jul 16;10:1118. doi: 10.3389/fonc.2020.01118. eCollection 2020.
Front Oncol. 2020.
PMID: 32766144
Free PMC article.
Item in Clipboard
Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment.
Yue E, Yang G, Yao Y, Wang G, Mohanty A, Fan F, Zhao L, Zhang Y, Mirzapoiazova T, Walser TC, Rodriguez-Rodriguez L, Fong Y, Salgia R, Wang EW.
Yue E, et al. Among authors: wang ew.
Cancers (Basel). 2021 Aug 24;13(17):4265. doi: 10.3390/cancers13174265.
Cancers (Basel). 2021.
PMID: 34503075
Free PMC article.
Item in Clipboard
Complete Pathologic Response to PARP Inhibitor Olaparib in a Patient with Stage IVB Recurrent Endometrioid Endometrial Adenocarcinoma.
Senguttuvan RN, Wei C, Raoof M, Dellinger TH, Wang EW.
Senguttuvan RN, et al. Among authors: wang ew.
J Clin Med. 2023 Jun 4;12(11):3839. doi: 10.3390/jcm12113839.
J Clin Med. 2023.
PMID: 37298034
Free PMC article.
Item in Clipboard
Cite
Cite